BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9436646)

  • 1. Increased expression of mRNA for myocyte-specific enhancer binding factor (MEF) 2C in the cerebral cortex of the itching mouse.
    Tohda C; Yamaguchi T; Kuraishi Y
    Neurosci Res; 1997 Nov; 29(3):209-15. PubMed ID: 9436646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of Byakko-ka-ninjin-to on itch in a mouse model of atopic dermatitis.
    Tohda C; Sugahara H; Kuraishi Y; Komatsu K
    Phytother Res; 2000 May; 14(3):192-4. PubMed ID: 10815013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of supraspinal antisense oligodeoxynucleotide treatment on delta-opioid receptor mRNA levels in mice.
    Lee CE; Kest B; Jenab S; Inturrisi CE
    Brain Res Mol Brain Res; 1997 Aug; 48(1):17-22. PubMed ID: 9379841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocyte-specific enhancer binding factor 2C expression in human brain development.
    Leifer D; Golden J; Kowall NW
    Neuroscience; 1994 Dec; 63(4):1067-79. PubMed ID: 7700509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocyte enhancer factor (MEF) 2C: a tissue-restricted member of the MEF-2 family of transcription factors.
    Martin JF; Schwarz JJ; Olson EN
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5282-6. PubMed ID: 8506376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocyte-specific enhancer binding factor 2C expression in fetal mouse brain development.
    Leifer D; Li YL; Wehr K
    J Mol Neurosci; 1997 Apr; 8(2):131-43. PubMed ID: 9188042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of myocardial myocyte enhancer factor 2C and myocyte enhancer factor 2C-regulated gene expression in diabetic patients with nonischemic heart failure.
    Razeghi P; Young ME; Cockrill TC; Frazier OH; Taegtmeyer H
    Circulation; 2002 Jul; 106(4):407-11. PubMed ID: 12135937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominant-interfering forms of MEF2 generated by caspase cleavage contribute to NMDA-induced neuronal apoptosis.
    Okamoto S; Li Z; Ju C; Scholzke MN; Mathews E; Cui J; Salvesen GS; Bossy-Wetzel E; Lipton SA
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3974-9. PubMed ID: 11904443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracerebroventricular administration of missense oligodeoxynucleotide induces interleukin-6 mRNA expression in brain and spleen of rats.
    Pezeshki G; Schöbitz B; Pohl T; Reul JM
    Neurosci Lett; 1996 Oct; 217(2-3):97-100. PubMed ID: 8916081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different perception levels of histamine-induced itch sensation in young adult mice.
    Ji Y; Jang Y; Lee WJ; Yang YD; Shim WS
    Physiol Behav; 2018 May; 188():188-193. PubMed ID: 29432788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A method to induce stable atopic dermatitis-like symptoms in NC/Nga mice housed with skin-lesioned mice.
    Takano N; Arai I; Kurachi M
    Br J Dermatol; 2006 Mar; 154(3):426-30. PubMed ID: 16445770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain-derived neurotrophic factor stimulates the transcriptional and neuroprotective activity of myocyte-enhancer factor 2C through an ERK1/2-RSK2 signaling cascade.
    Wang Y; Liu L; Xia Z
    J Neurochem; 2007 Aug; 102(3):957-66. PubMed ID: 17630987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of IL-31 on scratching behavior in NC/Nga mice with atopic-like dermatitis.
    Takaoka A; Arai I; Sugimoto M; Honma Y; Futaki N; Nakamura A; Nakaike S
    Exp Dermatol; 2006 Mar; 15(3):161-7. PubMed ID: 16480423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COX-1 inhibition enhances scratching behaviour in NC/Nga mice with atopic dermatitis.
    Sugimoto M; Arai I; Futaki N; Hashimoto Y; Honma Y; Nakaike S
    Exp Dermatol; 2006 Aug; 15(8):582-8. PubMed ID: 16842596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense 'knockdowns' of M1 receptors induces transient anterograde amnesia in mice.
    Ghelardini C; Galeotti N; Matucci R; Bellucci C; Gualtieri F; Capaccioli S; Quattrone A; Bartolini A
    Neuropharmacology; 1999 Mar; 38(3):339-48. PubMed ID: 10219972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High level expression in soluble form, one step purification, and characterization of the DNA binding domain of MEF-2C.
    Meierhans D; Allemann RK
    Protein Expr Purif; 1997 Dec; 11(3):297-303. PubMed ID: 9425635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A muscle-specific enhancer within intron 1 of the human dystrophin gene is functionally dependent on single MEF-1/E box and MEF-2/AT-rich sequence motifs.
    Klamut HJ; Bosnoyan-Collins LO; Worton RG; Ray PN
    Nucleic Acids Res; 1997 Apr; 25(8):1618-25. PubMed ID: 9092671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single dose of interleukin-31 (IL-31) causes continuous itch-associated scratching behaviour in mice.
    Arai I; Tsuji M; Takeda H; Akiyama N; Saito S
    Exp Dermatol; 2013 Oct; 22(10):669-71. PubMed ID: 24079740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation and alternative pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity.
    Zhu B; Gulick T
    Mol Cell Biol; 2004 Sep; 24(18):8264-75. PubMed ID: 15340086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of IL-31 gene transcripts in NC/Nga mice with atopic dermatitis.
    Takaoka A; Arai I; Sugimoto M; Yamaguchi A; Tanaka M; Nakaike S
    Eur J Pharmacol; 2005 Jun; 516(2):180-1. PubMed ID: 15925362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.